1. Academic Validation
  2. Esculin Alleviates Osteoarthritis Progression Through the Sirt1/NF-κB Pathway

Esculin Alleviates Osteoarthritis Progression Through the Sirt1/NF-κB Pathway

  • Phytother Res. 2024 Oct 1. doi: 10.1002/ptr.8349.
Tao Sun 1 2 Bingli Bai 3 Haohao Wu 1 2 Hailin Xing 1 2 Jian Li 1 2
Affiliations

Affiliations

  • 1 Department of Orthopedics, Lishui Central Hospital, Lishui, Zhejiang, China.
  • 2 Department of Orthopedics, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, China.
  • 3 Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Abstract

Osteoarthritis (OA), a joint disease associated with inflammatory processes, contributes to joint destruction. Esculin (ESC) extracted from the stem bark of Fraxinus rhynchophylla Hance has been shown to possess anti-inflammatory properties. In this study, we investigated the effect of ESC on chondrocytes treated with IL-1β and its molecular mechanism. The importance and potential mechanism of ESC in the progression of OA were evaluated. The viability of chondrocytes after exposure to ESC was examined through the CCK-8 assays. The cells were then subjected to quantitative polymerase chain reaction (qPCR), western blot, and enzyme-linked immunosorbent assay (ELISA) techniques to analyze the degradation of the extracellular matrix (ECM) and occurrence of inflammation. The NF-κB mechanism was evaluated by western blot analysis, immunofluorescence (IF), and luciferase reporter assay. Molecular docking was performed to allow for predictions on proteins that interact with ESC. Moreover, the significance of SIRT1 was explored through a knockdown experiment based on siRNA. Micro-computed tomography (CT), H&E, Safranin O-Fast Green (S-O), and immunohistochemical analyses were carried out to assess the treatment efficacy of ESC on OA in destabilization of medial meniscus (DMM) models. ESC treatment effectively inhibited ECM degradation, modulated the levels of pro-inflammatory factors, and regulated the NF-κB signaling in chondrocytes exposed to IL-1β. Mechanistically, we found that ESCs bound to SIRT1 to inhibit the activity of the NF-κB mechanism. Furthermore, ESC treatment suppressed OA progression in the DMM models. Our findings reveal that ESC ameliorates OA progression via modulating the SIRT1/NF-κB axis. This demonstrates that ESC has the potential to be applied in the treatment of OA.

Keywords

Esculin; NF‐κB; Sirt1; inflammation; osteoarthritis.

Figures
Products
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》